White Paper: Advanced Therapies Guide

Quality Management System readiness guide for cell therapies, gene therapies, and cancer vaccines 

White PaperQuality management strategy title page.png

Amid COVID-19, Quality Management matters more than ever for cell and gene therapy. Use this white paper to build on essential Quality and risk-management principles, including important information on critical risks, vendor management, and Quality metrics specific to advanced therapies.

Overview

Get the foundation your team needs with QMS principles to de-risk the complex advanced therapy supply chain.

  • Reduce supply chain risk
  • Enable identification of the critical supply chain risks, and identify where to deploy limited resources for the biggest benefit
  • Deploy partner management and metrics resources to provide actionable information that can be implemented immediately
Please enter your details for downloads
Required
Required
Required
Required
Required